A Study of LY3549492 in Participants With Type 2 Diabetes Mellitus (T2DM)
Clinical trial NCT05327595 · COMPLETED
Trial details
- NCT number
- NCT05327595
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-09
- Primary completion
- 2024-04-22
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.